ViiV Healthcare in the AusTender register. ViiV Healthcare shows 1 federal contract worth $2,887,500 in the AusTender register since September 2021, in December 2022, across 1 agency.
Assay record ASY-AU-1TATPHE140 · Cite as: Assay Systems, “ViiV Healthcare in the AusTender register”, https://assay-systems.com/register/au/viiv-healthcare/
ViiV Healthcare shows 1 federal contract worth $2,887,500 in the AusTender register since September 2021, in December 2022, across 1 agency.
No contract is recorded for ViiV Healthcare since January 2024. The last entry is dated December 2022.
Your line in the register: Drugs and Pharmaceutical Products (51000000)
Since January 2024 the line carries 169 contracts worth $3,139,911,956 from 8 agencies.
It carried $681,516,586 in 2024, $1,277,904,031 in 2025 and $1,180,491,340 in the first 9 months of 2026.
64 suppliers share it. ViiV Healthcare holds no contract in it since January 2024.
Agencies that have not bought from ViiV Healthcare since September 2021
8 agencies have bought this line since 2024 and have held no contract with ViiV Healthcare since September 2021: 169 contracts worth $3,139,911,956.
One of those agencies alone accounts for 15 of them, worth $2,265,474,747.
146 contracts since 2024, worth $486,683,652, were awarded by limited tender, without an open approach to the market.
ViiV Healthcare was the supplier on none of them.
134 of the 169 contracts in the 8 agencies were under $125,000 each, $3,451,414 in total. Below $125,000 the Commonwealth Procurement Rules allow an entity to approach one or more suppliers directly, without an open tender.
25 contracts in the line, worth $1,072,815,503, reach their end dates by September 2027.
19 of them, worth $1,072,040,824, end in the same month, June 2027.
22 of them, worth $1,072,152,170, sit in the 8 agencies that have not bought from ViiV Healthcare since September 2021.
From $225,245,000 in 2022 and 2023 to $1,246,399,747 in 2024 to 2026, 453 percent. It sells the same line.
Assay Systems reads large volumes of public procurement data and returns commercial intelligence.
The extract for ViiV Healthcare can be prepared in the shortest time. It will name the 8 agencies and the buying office. For each contract it will name who holds it now, the value, the contract number and the end date, and the notices behind every figure.
GlaxoSmithKline Australia Pty Ltd: 3 contracts worth $1,246,399,747 from 1 agency since 2024, up 453 percent on 2022 to 2023.
Pfizer Australia Pty Ltd: 4 contracts worth $359,394,167 from 2 agencies since 2024, up 33 percent on 2022 to 2023.
CH2: 8 contracts worth $352,587,110 from 3 agencies since 2024.
The extract for this line names every department and buying office behind the figures above, who holds each contract now, its value, contract number and end date, and the notices behind every figure.
Source: AusTender Contract Notice Export, Department of Finance, Commonwealth of Australia, via data.gov.au, licensed under Creative Commons Attribution 3.0 Australia; accessed 25 September 2026.Assay Systems has changed the data.